EUVIMEDEUVIMED entdecken
Crossref

Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis

Jian Jia, Ruizhi Tan, Linghui Xu, Honglian Wang, Jianchun Li, Hongwei Su, Xia Zhong, Peng Liu, Li Wang

International Immunopharmacology · 2024-06 · 135 · 112303

DOI: 10.1016/j.intimp.2024.112303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Jian Jia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Ferroptosis, Smad3 Protein, Diabetic Nephropathies, NADPH Oxidase 4. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a common complication of diabetes, characterized by renal fibrosis and poor patient prognosis. Hederagenin (HDG) has shown promising improvement in chronic kidney disease (CKD) kidney fibrosis, but its mechanism in DN-induced kidney fibrosis remains unclear. In this study, a model of diabetic nephropathy (DN) in mice was induced by intraperitoneal injection of streptozocin (50 mg/kg), while in vitro, high glucose (25 mM) was used to induce HK2 cell damage, simulating tubular injury in DN kidneys. The improvement of HDG treatment intervention was evaluated by observing changes in renal function, pathological structural damage, and the expression of fibrosis-related proteins in renal tubular cells. The results demonstrate that HDG intervention alleviates renal dysfunction and pathological damage in DN mice, accompanied by reduced expression of fibrotic markers α-smooth muscle actin (α-SMA), fibronectin (FN) and Collagen-I. Mechanistically, this study found that HDG can inhibit ferroptosis and fibrosis induced by the ferroptosis inducer Erastin (1 μM) in renal tubular cells. Phosphorylation of Smad3 promotes ferroptosis in renal tubular cells. After using its specific inhibitor SIS3 (4 μM), the expression of downstream target protein NADPH oxidase 4 (NOX4) significantly decreases, while the level of glutathione peroxidase 4 (GPX4) is notably restored, mitigating ferroptosis. Smad3 overexpression attenuates the therapeutic effect of HDG on tubular cell fibrosis induced by high glucose. These results demonstrate HDG inhibits Smad3 phosphorylation, thereby reducing the expression of NOX4 and enhancing the expression of GPX4, ultimately attenuating ferroptosis induced renal fibrosis. These findings suggest that HDG offer therapeutic potential for DN renal fibrosis by targeting Smad3-mediated ferroptosis in renal tubular cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSmad3 ProteinDiabetic NephropathiesNADPH Oxidase 4FibrosisSignal TransductionMice, Inbred C57BLOleanolic AcidAnimalsHumansMiceMaleCell LineKidney TubulesDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

Diabetic NephropathyFerroptosisFibrosisHederageninSmad3

Substanzen

Smad3 ProteinNADPH Oxidase 4Oleanolic AcidSmad3 protein, mouseNox4 protein, mouse

Autor:innen und Institutionen

  • Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
  • Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, China.
  • Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, China. Electronic address: liupeng1@xnykdhbszyy.onexmail.com.
  • Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China. Electronic address: wangli120@swmu.edu.cn.

Zitieren

APA

Jia, J., Tan, R., Xu, L., Wang, H., Li, J., Su, H., Zhong, X., Liu, P., & Wang, L. (2024). Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis. International Immunopharmacology, 135, 112303. https://doi.org/10.1016/j.intimp.2024.112303

Vancouver

Jia J, Tan R, Xu L, Wang H, Li J, Su H, et al. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis. International Immunopharmacology. 2024;135:112303. doi:10.1016/j.intimp.2024.112303

BibTeX
@article{Jia2024,
  author = {Jia, Jian and Tan, Ruizhi and Xu, Linghui and Wang, Honglian and Li, Jianchun and Su, Hongwei and Zhong, Xia and Liu, Peng and Wang, Li},
  title = {Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {135},
  pages = {112303},
  doi = {10.1016/j.intimp.2024.112303}
}
Kostenlos starten →